Edwin Ofori Atta on Permissive Hypertension For Ischemic Stroke
Edwin Ofori Atta, Head Of Pharmacy at Kumasi Hospital, shared on LinkedIn:
”Permissive Hypertension For Ischemic Stroke
In 2026, permissive hypertension remains a standard temporary management strategy for acute ischemic stroke.
It involves intentionally allowing a patient’s blood pressure (BP) to remain elevated to ensure adequate blood flow to the ischemic penumbra—the salvageable brain tissue surrounding the core area of the stroke.
It’s purposely done to maximize cerebral perfusion and promote collateral circulation when the brain’s natural autoregulation of blood flow is impaired.
It’s typically maintained for the first 24hrs to 48hrs following stroke onset.
It’s Primarily candidates are patients with acute ischemic stroke who are not candidates for immediate reperfusion therapies (like “clot-busting” drugs) or those whose BP is high but below dangerous thresholds (<220/120 mmHg)”
Stay updated with Hemostasis Today.
-
Jul 3, 2026, 13:31Javed Anees: TIA is a Medical Emergency – Not a Benign Warning
-
Jul 3, 2026, 12:46Heghine Khachatryan: 2026 AHA Guideline on the Management of CKM Syndrome
-
Jul 3, 2026, 12:32Shadi Tabibian: Beyond Bleeding – Women Living with von Willebrand Disease
-
Jul 3, 2026, 09:33Abdul Mannan: Not All Type 1 VWD Starts in the VWF Gene
-
Jul 3, 2026, 09:18Aryabhatta Sadhu: Sickle Cell Crisis – When Diagnostics Should Change Therapy
-
Jul 3, 2026, 05:55New Evidence Supports Chromogenic Assays After Hemophilia A Gene Therapy – JTH
-
Jul 3, 2026, 05:50Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
-
Jul 3, 2026, 05:25Brian A Beh: A New Approach from The George Institute for Global Health Could Transform Stroke Care Before Hospital Arrival
-
Jul 3, 2026, 05:22Deirdre Finnigan: New Insights into Red Blood Cell Biomechanics in Cancer-Associated Anemia